Correction: GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease.
作者信息
Sachs Stephan, Götz Anna, Finan Brian, Feuchtinger Annette, DiMarchi Richard D, Döring Yvonne, Weber Christian, Tschöp Matthias H, Müller Timo D, Hofmann Susanna M
机构信息
Institute for Diabetes and Regeneration, Helmholtz Diabetes Center at Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), 85764, Neuherberg, Germany.
Institute for Diabetes and Obesity, Division of Metabolic Diseases, Helmholtz Diabetes Center at Helmholtz Centre Munich, Munich, Germany.
出版信息
Cardiovasc Diabetol. 2024 Sep 12;23(1):341. doi: 10.1186/s12933-024-02407-8.
Abstract
摘要
Zotero 插件